Clinical trial
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853
Study timeline
Study start (actual)2023-03-28Date precision: day
Registry last updated2024-06-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosis, Relapsing-Remittingunresolved
Multiple Sclerosis, Primary Progressiveunresolved
Interventions
Sponsors & collaborators
LAPIX Therapeutics Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05663853 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.